These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 1648214)
1. The role of the kallikrein-kinin system in joint inflammatory disease. Sharma JN Pharmacol Res; 1991 Feb; 23(2):105-12. PubMed ID: 1648214 [TBL] [Abstract][Full Text] [Related]
2. The role of kinin system in joint inflammatory disease. Sharma JN Eur J Rheumatol Inflamm; 1991; 11(2):30-7. PubMed ID: 1365470 [TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy. Sharma JN; Yusof AP Inflammopharmacology; 1998; 6(4):289-96. PubMed ID: 17657626 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the kinin-forming system in the physiopathology of rheumatoid inflammation. Sharma JN Agents Actions Suppl; 1992; 38 ( Pt 3)():343-61. PubMed ID: 1334358 [TBL] [Abstract][Full Text] [Related]
5. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis. Cassim B; Shaw OM; Mazur M; Misso NL; Naran A; Langlands DR; Thompson PJ; Bhoola KD Rheumatology (Oxford); 2009 May; 48(5):490-6. PubMed ID: 19254919 [TBL] [Abstract][Full Text] [Related]
7. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Marcondes S; Antunes E Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742 [TBL] [Abstract][Full Text] [Related]
8. Ontogeny of the intrarenal kallikrein-kinin system: proposed role in renal development. el-Dahr SS Microsc Res Tech; 1997 Nov; 39(3):222-32. PubMed ID: 9372496 [TBL] [Abstract][Full Text] [Related]
9. [Significance of kallikrein-kinin system in central nervous system diseases]. Stadnicka I; Strzałka-Mrozik B; Solarz K; Stadnicki A Wiad Lek; 2018; 71(8):1615-1620. PubMed ID: 30684349 [TBL] [Abstract][Full Text] [Related]
10. Development biology of the renal kallikrein-kinin system. el-Dahr SS Pediatr Nephrol; 1994 Oct; 8(5):624-31. PubMed ID: 7819016 [TBL] [Abstract][Full Text] [Related]
11. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor. Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912 [TBL] [Abstract][Full Text] [Related]
12. Genetically altered animal models in the kallikrein-kinin system. Pesquero JB; Bader M Biol Chem; 2006 Feb; 387(2):119-26. PubMed ID: 16497143 [TBL] [Abstract][Full Text] [Related]
13. The kallikrein-kinin system: current and future pharmacological targets. Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542 [TBL] [Abstract][Full Text] [Related]
15. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases. Schremmer-Danninger E; Naidoo S; Neuhof C; Valeske K; Snyman C; Sander C; Bhoola KD; Neuhof H Biol Chem; 2004 Nov; 385(11):1069-76. PubMed ID: 15576327 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. Sharma JN; Al-Sherif GJ ScientificWorldJournal; 2006 Oct; 6():1247-61. PubMed ID: 17041716 [TBL] [Abstract][Full Text] [Related]
17. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Sharma JN; Buchanan WW Exp Toxicol Pathol; 1994 Dec; 46(6):421-33. PubMed ID: 7703672 [TBL] [Abstract][Full Text] [Related]
18. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Ma JX; Song Q; Hatcher HC; Crouch RK; Chao L; Chao J Exp Eye Res; 1996 Jul; 63(1):19-26. PubMed ID: 8983960 [TBL] [Abstract][Full Text] [Related]
19. T-kininogen, processing and functions. Greenbaum LM; Howard E; Albus U; Lapp C; Gao XX Agents Actions Suppl; 1992; 38 ( Pt 1)():300-6. PubMed ID: 1281610 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and characterisation of kinins and Hoe 140 (kinin antagonist) in the synovial fluid of patients with inflammatory joint diseases. Bond AP; Breipohl G; Worthy K; Campion G; Dieppe PA; Bhoola KD Agents Actions Suppl; 1992; 38 ( Pt 1)():582-9. PubMed ID: 1466299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]